Contrave : Across multiple clinical trials, people taking Contrave lost an average of 5%9% of their starting body weight over 56 weeks compared to placebo
Controlled study on L-carnitine therapeutic efficacy in post-infarction
A 2025 systematic review and meta-analysis in men with overweight or obesity found that GLP-1 RAs increased total testosterone, luteinizing hormone, and follicle-stimulating hormone levels, while reducing body weight, BMI, waist circumference, and A1c
Browse the comparison chart below, which will allow you to see what is included at each level, and contact us with any questions
Dosing concerns with compounded semaglutide and tirzepatide FDA received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products